Page 12 – PHI

BioStock: The five best life science stocks of the first half-year

PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.

Three purple A549 cells on bright yellow background. They all originate from one single mother cell.

Applied Sciences Special Issue: Novel Approaches of Digital Holographic Microscopy in Cell Biology

PHI CSO Kersti Alm invites you to join this Applied Sciences Special Issue highlighting Digital Holographic Microscopy in Cell Biology.

Artistic image of molecularly imprinted polymers (MIP).

European Patent Office intends to grant PHI patent on synthetic antibodies

PHI AB announces today that the European Patent Office (EPO) intends to grant a patent on synthetic antibodies.

PHI visit WFIRM – Inside the World of Regenerative Medicine

PHI headed to the Wake Forest Institute for Regenerative Medicine (WFIRM) in Winston-Salem to visit, collaborate and attend the World Stem Cell Summit 2023.

HoloMonitor M4FL in the spotlight at EACR and ISSCR 2023

Recapping the scientific conferences EACR and ISSCR 2023 that put HoloMonitor M4FL in the spotlight at its world premiere.

BioStock: PHI’s CEO reflects on global roadshow success

BioStock contacted CEO Patrik Eschricht to learn about the team’s achievements on their global roadshow this early summer.

BIOSpektrum application article highlights HoloMonitor technology (in German)

PHI’s CSO, Kersti Alm, and Head of Communication, Lisa Bodily, have recently contributed to the June 2023 issue of the German BIOSpektrum journal. Their application article sheds light on how HoloMonitor’s technology is applied for non-invasive live cell analysis.

Archives